[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper does not explicitly discuss a disease mechanism but implies EGFR mutations drive cancer cell proliferation and survival.",
        "judgment": "Yes",
        "reasoning": "While not explicitly stated, the EGFR mutations are inferred to be critical for cancer growth.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The enzyme activity assay is a common approach for evaluating the impact of mutations in tyrosine kinase domains of receptor tyrosine kinases and is standard practice in cancer research.",
        "judgment": "Yes",
        "reasoning": "Enzyme assays are frequently used to evaluate the functional impact of mutations in receptor tyrosine kinases and are thus applicable here.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays.",
        "extracted_paper_info": "The paper details the use of appropriate controls: wild-type EGFR protein, and states results were reproduced in three independent experiments.",
        "judgment": "Yes",
        "reasoning": "The presence of control proteins and explicit mention of replicates indicate adequate controls.",
        "next_step_or_outcome": "Proceed to Step 3c"
      },
      {
        "step_name": "Step 3c: Variant Controls",
        "extracted_paper_info": "The paper does not state that multiple pathogenic or benign variants were used as controls.",
        "judgment": "No",
        "reasoning": "The paper doesn't describe using known pathogenic or benign EGFR variants as controls.",
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation. Statistical Analyses",
        "extracted_paper_info": "No OddsPath calculation is given, nor any formal statistical analysis.",
        "judgment": "No",
        "reasoning": "There is a lack of formal statistical information given for this specific variant and assay.",
        "next_step_or_outcome": "Proceed to Step 4b"
      },
      {
        "step_name": "Step 4b: No OddsPath Calculation",
        "extracted_paper_info": "The paper doesn't state how many total benign/pathogenic control variants were used.",
        "judgment": "No",
        "reasoning": "This information is lacking.",
        "next_step_or_outcome": "Final evidence strength determination"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_supporting"
    },
    "overall_conclusion": "The enzyme activity assay demonstrates a functional effect of the L858R mutation, but lack of specific statistical information or control variant data limits the strength of the evidence to PS3_supporting."
  }
]